The online version of this article (doi:10.1186/1752-1947-8-268) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
HK examined and diagnosed the patient’s disease and treated the patient. HK also wrote draft manuscript. KS helped in the analysis of the bone marrow data and refined the manuscript. SH, SY and MT analyzed the karyotype of the patient and researched previously reported similar cases. SK, MO, YT, and TI assisted in the therapeutic management of the patient. YO critically read the manuscript. All authors read and approved the final manuscript.
Deletions of chromosome 7 are often detected in myelodysplastic syndrome. The most commonly deleted segments are clustered at band 7q22. A critical gene is therefore suggested to be located in this region. We report a patient with myelodysplastic syndrome whose marrow cells carried an inversion of 7q22 and q36 as a sole karyotypic abnormality. How this extremely rare chromosomal aberration contributes to the pathogenesis of myelodysplastic syndrome should be clarified by accumulating clinical data of such cases.
A 74-year-old Japanese man presented with pancytopenia incidentally detected by routine medical check-up. His complete blood cell counts revealed that his white blood cells had decreased to 2100/mm3, neutrophils 940/mm3, red blood cells 320×104/mm3, hemoglobin 11.1g/dL, hematocrit 33.1%, and platelets 12.6×104/mm3. Bone marrow examination showed normal cellularity with nucleated cells of 9.4×104/mm3. The proportion of blasts was 4%. A morphological examination showed only basophilic stippling of erythroblasts which was seen as dysplasia. According to World Health Organization classification, the diagnosis was myelodysplastic syndrome-u. Karyotypic analysis showed 46,XY,inv(7)(q22q36) in all of 20 metaphases examined. Additional analysis revealed the karyotype of his lymphocytes was 46,XY. He is asymptomatic and cytopenia has slowly progressed.
To the best of our knowledge, this karyotype from a clinical sample of de novo malignancies has never been documented although the identical karyotype from secondary myelodysplastic syndrome was reported. Despite the extremely low frequency, inversion of 7q22 appears to play a crucial role for myelodysplastic syndrome in this patient.
Authors’ original file for figure 113256_2014_2894_MOESM1_ESM.pdf
Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997, 89: 2079-2088. PubMed
Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood. 1996, 88: 1930-1935. PubMed
Johnson EJ, Scherer SW, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE: Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood. 1996, 87: 3579-3586. PubMed
Fischer K, Frohling S, Scherer SW, Brown JM, Scholl C, Stilgenbauer S, Tsui LC, Lichter P, Dohner H: Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood. 1997, 89: 2036-2041. PubMed
Swerdlow SH, Campo E, Harris NL: WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 2008, Lyon: IARC
Shaffer LG, Slovak ML, Campbell LJ: ISCN: International System of Human Cytogenetic Nomenclature. 2009, Basel: Karger AG
McNerney ME, Brown CD, Wang X, Bartom ET, Karmakar S, Bandlamdi C, Yu S, Ko J, Sandall BP, Stricker T, Anastasi J, Grossman RL, Cunningham JM, Le Beau MM, White KP: CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood. 2013, 121: 975-983. 10.1182/blood-2012-04-426965. CrossRefPubMedPubMedCentral
Wong CC, Martincorena I, Rust AG, Rashid M, Alifrangis G, Alexandrov LB, Tiffen JC, Kober C, Green AR, Massie CE, Nangalia J, Lempidaki S, Dohner H, Dohner K, Bray SJ, McDermott U, Papaemmanuil E, Campbell PJ, Adams DJ: Inactivating CUX1 mutations promote tumorigenesis. Nat Genet. 2014, 46: 33-38. CrossRefPubMed
- Inversion of chromosome 7q22 and q36 as a sole abnormality presenting in myelodysplastic syndrome: a case report
- BioMed Central